IDR 57.0
(0.0%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 75.23 Billion IDR | -26.04% |
2022 | 96.26 Billion IDR | -46.25% |
2021 | 179.1 Billion IDR | 93.34% |
2020 | 92.63 Billion IDR | 107.95% |
2019 | 44.54 Billion IDR | -33.29% |
2018 | 66.78 Billion IDR | 38.91% |
2017 | 48.07 Billion IDR | 59.45% |
2016 | 30.15 Billion IDR | 132.81% |
2015 | 12.95 Billion IDR | 179.25% |
2014 | 4.63 Billion IDR | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q2 | 10.45 Billion IDR | -28.6% |
2024 Q3 | 15.94 Billion IDR | 52.57% |
2024 Q1 | 14.64 Billion IDR | -58.07% |
2023 Q4 | 34.91 Billion IDR | 96.99% |
2023 FY | 71.2 Billion IDR | -26.04% |
2023 Q1 | 10.94 Billion IDR | -61.01% |
2023 Q3 | 17.72 Billion IDR | 54.0% |
2023 Q2 | 11.51 Billion IDR | 5.17% |
2022 Q1 | 22.39 Billion IDR | 674.19% |
2022 Q3 | 20.23 Billion IDR | -20.88% |
2022 Q4 | 28.06 Billion IDR | 38.71% |
2022 FY | 96.26 Billion IDR | -46.25% |
2022 Q2 | 25.57 Billion IDR | 14.2% |
2021 FY | 179.1 Billion IDR | 93.34% |
2021 Q1 | 34.34 Billion IDR | 10.66% |
2021 Q2 | 71.16 Billion IDR | 107.22% |
2021 Q3 | 77.49 Billion IDR | 8.9% |
2021 Q4 | -3.89 Billion IDR | -105.03% |
2020 Q3 | 34.56 Billion IDR | 192.96% |
2020 Q2 | 11.79 Billion IDR | -22.56% |
2020 Q1 | 15.23 Billion IDR | 6662.09% |
2020 FY | 92.63 Billion IDR | 107.95% |
2020 Q4 | 31.03 Billion IDR | -10.22% |
2019 Q1 | 14.53 Billion IDR | -0.61% |
2019 FY | 44.54 Billion IDR | -33.29% |
2019 Q4 | 225.33 Million IDR | -98.56% |
2019 Q3 | 15.65 Billion IDR | 10.84% |
2019 Q2 | 14.12 Billion IDR | -2.81% |
2018 FY | 66.78 Billion IDR | 38.91% |
2018 Q1 | 17.22 Billion IDR | 272.43% |
2018 Q2 | 12.88 Billion IDR | -25.19% |
2018 Q3 | 22.05 Billion IDR | 71.18% |
2018 Q4 | 14.62 Billion IDR | -33.69% |
2017 Q1 | 15.95 Billion IDR | 0.0% |
2017 Q4 | -9.98 Billion IDR | -138.18% |
2017 Q2 | 15.95 Billion IDR | 0.0% |
2017 Q3 | 26.16 Billion IDR | 64.0% |
2017 FY | 48.07 Billion IDR | 59.45% |
2016 FY | 30.15 Billion IDR | 132.81% |
2015 FY | 12.95 Billion IDR | 179.25% |
2014 FY | 4.63 Billion IDR | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
PT Bundamedik Tbk | 582.25 Billion IDR | 87.079% |
PT Metro Healthcare Indonesia Tbk | 89.65 Billion IDR | 16.082% |
PT Medikaloka Hermina Tbk | 1824.23 Billion IDR | 95.876% |
PT Mitra Keluarga Karyasehat Tbk | 1968.05 Billion IDR | 96.177% |
PT Murni Sadar Tbk | 167.6 Billion IDR | 55.111% |
PT Famon Awal Bros Sedaya Tbk | 515.99 Billion IDR | 85.419% |
PT Kedoya Adyaraya Tbk | 128.11 Billion IDR | 41.273% |
PT Sarana Meditama Metropolitan Tbk | 434.04 Billion IDR | 82.666% |
PT Siloam International Hospitals Tbk | 3644.9 Billion IDR | 97.936% |
PT Sejahteraraya Anugrahjaya Tbk | 718.02 Billion IDR | 89.522% |